tiprankstipranks
Trending News
More News >
Pharming Group (NL:PHARM)
:PHARM
Netherlands Market

Pharming Group (PHARM) Income Statement

Compare
0 Followers

Pharming Group Income Statement

Last quarter (Q4 2024), Pharming Group's total revenue was $92.67M, an increase of 13.20% from the same quarter last year. In Q4, Pharming Group's net income was $2.86M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 286.89M$ 245.32M$ 205.62M$ 189.85M$ 228.39M
Gross Profit
$ 252.72M$ 220.10M$ 188.06M$ 169.67M$ 203.06M
Operating Expenses
$ 261.04M$ 225.49M$ 169.83M$ 156.72M$ 120.97M
Depreciation and Amortization
$ 15.51M$ 15.93M$ 13.19M$ 19.61M$ 8.31M
EBITDA
$ 7.19M$ 9.88M$ 33.53M$ 48.78M$ 92.11M
Operating Income
$ -8.32M$ -4.88M$ 18.23M$ 27.84M$ 82.09M
Other Income/Expenses
$ 104.25K$ -7.13M$ -3.25M$ -4.76M$ -18.33M
Pretax Income
$ -8.22M$ -12.01M$ 14.99M$ 22.03M$ 47.47M
Net Income
$ -10.64M$ -10.55M$ 13.67M$ 16.00M$ 37.75M
Per Share Metrics
Basic EPS
$ -0.02$ -0.01$ 0.02$ 0.02$ 0.05
Diluted EPS
$ -0.02$ -0.01$ 0.02$ 0.02$ 0.04
Weighted Average Shares Outstanding
689.19M 821.28M 883.93M 876.44M 853.42M
Weighted Average Shares Outstanding (Diluted)
689.19M 843.25M 883.93M 876.44M 853.42M
Currency in USD

Pharming Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis